Page 4 - Steven Pfanstiel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven pfanstiel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Pfanstiel Today - Breaking & Trending Today

Oppenheimer Downgrades Marinus Pharmaceuticals (NASDAQ:MRNS) to Market Perform

Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) was downgraded by equities research analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research note issued to investors on Friday, MarketBeat reports. They presently have a $9.00 price objective on the biopharmaceutical company’s stock, down from their previous price objective of $14.00. […] ....

Robertw Baird , Scott Braunstein , Steven Pfanstiel , Marinus Pharmaceuticals Company Profile , Analyst Recommendations For Marinus Pharmaceuticals , Life Insurance Co , Marinus Pharmaceuticals , Ameritas Investment Partners Inc , Marinus Pharmaceuticals Inc , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals Price Performance , Charles Schwab Investment Management Inc , Get Free Report , Truist Financial , Schwab Investment Management , Investment Partners , Quantbot Technologies , Marinus Pharmaceuticals Daily , Nasdaq Mrns , Oppenheimer Holdings Inc ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Releases Earnings Results, Beats Estimates By $0.15 EPS

Marinus Pharmaceuticals (NASDAQ:MRNS) Releases Earnings Results, Beats Estimates By $0.15 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Robertw Baird , Steven Pfanstiel , Scott Braunstein , Securities Exchange Commission , Board Of Administration Florida Retirement System , Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Earnings History For Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals Stock Down , Institutional Investors Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals Company Profile , Blackrock Inc , Harvest Investment Services , Campbell Co Investment Adviser , Royal Bank , Ameritas Investment Partners Inc , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Investment Partners , Investment Services , State Board , Florida Retirement System , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) PT Lowered to $20.00 at Robert W. Baird

Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) had its price objective decreased by Robert W. Baird from $24.00 to $20.00 in a report issued on Friday, MarketBeat reports. Robert W. Baird currently has an outperform rating on the biopharmaceutical company’s stock. MRNS has been the topic of a number of other reports. Truist Financial cut their […] ....

Robertw Baird , Scott Braunstein , Steven Pfanstiel , Marinus Pharmaceuticals Inc , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Company Profile , Blackrock Inc , Jennison Associates , Marinus Pharmaceuticals Trading Down , News Ratings For Marinus Pharmaceuticals Daily , Free Report , Moderate Buy , Pharmaceuticals Trading Down , Get Free Report , Point Capital , Antara Capital , Marinus Pharmaceuticals Daily , Nasdaq Mrns , Lower Price Target ,

Insider Selling: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) CFO Sells $26,616.60 in Stock

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) CFO Steven Pfanstiel sold 2,790 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $9.54, for a total transaction of $26,616.60. Following the completion of the transaction, the chief financial officer now directly […] ....

Steven Pfanstiel , Marinus Pharmaceuticals Price Performance , Marinus Pharmaceuticals Company Profile , Mirae Asset Global Investments Co , Securities Exchange Commission , Marinus Pharmaceuticals Inc , Charles Schwab Investment Management Inc , Life Insurance Co , Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Metlife Investment Management , Institutional Trading Of Marinus Pharmaceuticals , Get Free Report , Exchange Commission , Life Investment Management , Asset Global Investments , Schwab Investment Management , Rhumbline Advisers , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) PT Lowered to $13.00 at LADENBURG THALM/SH SH

Marinus Pharmaceuticals (NASDAQ:MRNS) PT Lowered to $13.00 at LADENBURG THALM/SH SH
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Steven Pfanstiel , Scott Braunstein , Capital Management , Jennison Associates , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals , Millennium Management , Institutional Trading Of Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock Performance , Analyst Recommendations For Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Capital Corp , Get Free Report , Truist Financial , Marinus Pharmaceuticals Daily ,